Fermer le menu


Member of Lyonbiopole


IASO is developing multi-target bioproduction of therapeutic recombinant proteins inside microalgae cells. These fast-growing, single-cell microorganisms produce homogeneous batches of biomolecules by fermentation. Our strains of interest are qualified for biopharmaceuticals and can be used as vectors of proteins bioencapsulated in edible cells, and heat-stable. They also have advantages for ‘difficult-to-express’ proteins, for fusion proteins, for immunotoxins, thus opening new options in vaccinology, infectiology and oncology.


Strategic application domain: Human Medicine

Application market: Bioproduction, Infectious Diseases, Oncology

Type of activity: CMO - Production - Bioproduction, Therapeutics, Pharma or Biotech

Technologies: Antibodies - Protein - Peptide

Created on oct. 15th, 2020 - 1 employees



3 chemin des Balmes 69110 Sainte-Foy-lès-Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.